Funding for Hiberix and Varivax will cease from 1 December 2024.
The vaccines have been replaced by Act-HIB and Varilrix respectively. Practices should have stock of the new vaccines and should have already made the swap to these.
If you have old stock remaining on 1 December, it needs to be returned to Propharma using usual processes.
In general, please remember to retain a minimum of 2 weeks and maximum of 6 weeks stock so there is timely turnover. However, in the lead up to Christmas and New Year if you are going to be closed, please do ensure that you reduce your stock levels.
Offering both the flu and Zostavax (shingles) vaccines, a Hamilton initiative is reaching a high risk, vulnerable population who may otherwise have been missed.
Read moreAn Ōtākou Whakaihu Waka | University of Otago research study aims to develop tools and resources to increase vaccination of Māori and Pacific women in pregnancy. The research group is wanting to interview more practice nurses who deliver these vaccinations to hapū māmā, particularly in practices with high Māori and Pacific populations. Participation involves a one-hour kōrero via Zoom and participants will receive a $50 supermarket voucher as a thank you.
Read moreThe B4 School Check (B4SC) is a universal, comprehensive check for all four-year-old’s that includes height and weight, vision and hearing, immunisations, oral health, and behavioral and developmental components.
View detailsThe Aotearoa Immunisation Register (AIR) is replacing the aging National Immunisation Register (NIR).